These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 36741092)

  • 1. Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendees.
    Colom-Cadena A; Martínez-Riveros H; Bordas A; Alonso-García L; Montoro-Fernández M; Romano-deGea P; Vidal-Alaball J; Solà-Segura E; Llibre JM; Revollo B; Casabona J; Agustí C
    Front Pediatr; 2022; 10():975454. PubMed ID: 36741092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum: Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendees.
    Colom-Cadena A; Martínez-Riveros H; Bordas A; Alonso-García L; Montoro-Fernández M; Romano-deGea P; Vidal-Alaball J; Solà-Segura E; Llibre JM; Revollo B; Casabona J; Agustí C
    Front Pediatr; 2023; 11():1353806. PubMed ID: 38250593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and acceptability of SARS-CoV-2 testing and surveillance in primary school children in England: Prospective, cross-sectional study.
    Aiano F; Jones SEI; Amin-Chowdhury Z; Flood J; Okike I; Brent A; Brent B; Beckmann J; Garstang J; Ahmad S; Baawuah F; Ramsay ME; Ladhani SN
    PLoS One; 2021; 16(8):e0255517. PubMed ID: 34449784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and Acceptability of Community Coronavirus Disease 2019 Testing Strategies (FACTS) in a University Setting.
    Hirst JA; Logan M; Fanshawe TR; Mwandigha L; Wanat M; Vicary C; Perera R; Tonkin-Crine S; Lee JJ; Tracey I; Duff G; Tufano P; Besharov M; Tarassenko L; Nicholson BD; Hobbs FDR
    Open Forum Infect Dis; 2021 Dec; 8(12):ofab495. PubMed ID: 34904117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of At-Home Serial Testing Using Over-the-Counter SARS-CoV-2 Tests With a Digital Smartphone App for Assistance: Longitudinal Cohort Study.
    Herbert C; Broach J; Heetderks W; Qashu F; Gibson L; Pretz C; Woods K; Kheterpal V; Suvarna T; Nowak C; Lazar P; Ayturk D; Barton B; Achenbach C; Murphy R; McManus D; Soni A
    JMIR Form Res; 2022 Oct; 6(10):e35426. PubMed ID: 36041004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England.
    Ismail SA; Saliba V; Lopez Bernal J; Ramsay ME; Ladhani SN
    Lancet Infect Dis; 2021 Mar; 21(3):344-353. PubMed ID: 33306981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing and Mitigating SARS-CoV-2 Transmission - Four Overnight Camps, Maine, June-August 2020.
    Blaisdell LL; Cohn W; Pavell JR; Rubin DS; Vergales JE
    MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(35):1216-1220. PubMed ID: 32881850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-testing for SARS-CoV-2 in São Paulo, Brazil: results of a population-based values and attitudes survey.
    Martínez-Pérez GZ; Shilton S; Saruê M; Cesario H; Banerji A; Batheja D; Cunha JP; Baptista R; Schirmer J; Ivanova Reipold E; Machado Dias A
    BMC Infect Dis; 2022 Sep; 22(1):720. PubMed ID: 36056299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study.
    Macartney K; Quinn HE; Pillsbury AJ; Koirala A; Deng L; Winkler N; Katelaris AL; O'Sullivan MVN; Dalton C; Wood N;
    Lancet Child Adolesc Health; 2020 Nov; 4(11):807-816. PubMed ID: 32758454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated Transmission Outcomes and Costs of SARS-CoV-2 Diagnostic Testing, Screening, and Surveillance Strategies Among a Simulated Population of Primary School Students.
    Bilinski A; Ciaranello A; Fitzpatrick MC; Giardina J; Shah M; Salomon JA; Kendall EA
    JAMA Pediatr; 2022 Jul; 176(7):679-689. PubMed ID: 35442396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of Acute SARS-CoV-2 Infections in School Children and Point-Prevalence During a Time of High Community Transmission in Switzerland.
    Kriemler S; Ulyte A; Ammann P; Peralta GP; Berger C; Puhan MA; Radtke T
    Front Pediatr; 2021; 9():645577. PubMed ID: 33796490
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.
    Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Xavier Gómez-Olivé F; Dawood FS; Mkhencele T; Sun K; Viboud C; ; Tempia S
    medRxiv; 2021 Dec; ():. PubMed ID: 34909794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usability and Acceptability of Home-based Self-testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies for Population Surveillance.
    Atchison C; Pristerà P; Cooper E; Papageorgiou V; Redd R; Piggin M; Flower B; Fontana G; Satkunarajah S; Ashrafian H; Lawrence-Jones A; Naar L; Chigwende J; Gibbard S; Riley S; Darzi A; Elliott P; Ashby D; Barclay W; Cooke GS; Ward H
    Clin Infect Dis; 2021 May; 72(9):e384-e393. PubMed ID: 32785665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.